Highlights
1 patentProfile claimed by owner
About
Ophthalmic Cannabis Solutions
3R Pharma is developing high-end and complex cannabinoid-based pharmaceutical products to address chronic ocular diseases for patients around the world. These patent-pending cannabinoid-based medicines provide a novel treatment option for various conditions that are currently insufficiently addressed. The company's R&D unit, based in Israel, is licensed to conduct scientific and clinical research on cannabinoid formulations by the Ministry of Health IMC.
Identity
| Name | 3R Pharma |
|---|---|
| Slug | 3r-pharma |
| Former names | 3R Therapeutics |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAkIiG8vILDA |
Status
| Status | inactive |
|---|---|
| Status reason | Non Active, Apr 2026 ceased to operate |
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | South District |
| HQ city | Yeruham |
| HQ address | Yeruham, Israel |
Web & social
| https://www.linkedin.com/company/66921147 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentMedical Cannabis
Technologies
BiologicalsHerbals
Target customers
Healthcare & Life SciencesHealthcareProvidersLife SciencesPharmaceuticals
Business models
B2B
Tags
medical-cannabistherapeuticspharmaceuticalschronic-patientspatent-pendingcannabisophthalmologypatientstreatments
Funding
| Total raised | $800K |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}